A new publication involving abaloparatide was released on October 29, 2026. The study, titled "Bone anabolic agents repair alveolar bone damaged by diabetes in mice," appeared in the International Journal of Oral Science. The publication is listed under PubMed ID 42957662. This entry reflects the release of the study itself, not its conclusions. No findings, results, or outcomes from the study are detailed here. Readers interested in the specifics of the research should consult the original publication directly through the journal or PubMed listing. Abaloparatide remains an approved compound, and this publication represents new literature associated with it rather than a change in its regulatory standing. For general background on abaloparatide, readers can refer to the compound overview for additional context.
Abaloparatide Study Published on Bone Repair in Diabetic Mice
See the full abaloparatide overview
Source: https://pubmed.ncbi.nlm.nih.gov/42957662/